These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18546544)

  • 1. The use of linear instrumental variables methods in health services research and health economics: a cautionary note.
    Terza JV; Bradford WD; Dismuke CE
    Health Serv Res; 2008 Jun; 43(3):1102--20. PubMed ID: 18546544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Effect Estimation Using Nonlinear Two-Stage Instrumental Variable Estimators: Another Cautionary Note.
    Chapman CG; Brooks JM
    Health Serv Res; 2016 Dec; 51(6):2375-2394. PubMed ID: 26891780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
    Hogan JW; Lancaster T
    Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Stage Residual Inclusion Estimation in Health Services Research and Health Economics.
    Terza JV
    Health Serv Res; 2018 Jun; 53(3):1890-1899. PubMed ID: 28568477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The productivity of mental health care: an instrumental variable approach.
    Lu M
    J Ment Health Policy Econ; 1999 Jun; 2(2):59-71. PubMed ID: 11967410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using simulation-based inference with panel data in health economics.
    Contoyannis P; Jones AM; Leon-Gonzalez R
    Health Econ; 2004 Feb; 13(2):101-22. PubMed ID: 14737750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling.
    Terza JV; Basu A; Rathouz PJ
    J Health Econ; 2008 May; 27(3):531-43. PubMed ID: 18192044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are primary care services a substitute or complement for specialty and inpatient services?
    Fortney JC; Steffick DE; Burgess JF; Maciejewski ML; Petersen LA
    Health Serv Res; 2005 Oct; 40(5 Pt 1):1422-42. PubMed ID: 16174141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of unmeasured within- and between-cluster confounding on the bias of effect estimatorsof a continuous exposure.
    Li Y; Lee Y; Port FK; Robinson BM
    Stat Methods Med Res; 2020 Aug; 29(8):2119-2139. PubMed ID: 31694489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing causal treatment effect estimation when using large observational datasets.
    John ER; Abrams KR; Brightling CE; Sheehan NA
    BMC Med Res Methodol; 2019 Nov; 19(1):207. PubMed ID: 31726969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time dependent hazard ratio estimation using instrumental variables without conditioning on an omitted covariate.
    MacKenzie TA; Martinez-Camblor P; O'Malley AJ
    BMC Med Res Methodol; 2021 Mar; 21(1):56. PubMed ID: 33743583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to care and utilization among children: estimating the effects of public and private coverage.
    Selden TM; Hudson JL
    Med Care; 2006 May; 44(5 Suppl):I19-26. PubMed ID: 16625060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using physician practice cost functions in payment policy: the problem of endogeneity bias.
    Escarce JJ
    Inquiry; 1996; 33(1):66-78. PubMed ID: 8774375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some cautions on the use of instrumental variables estimators in outcomes research: how bias in instrumental variables estimators is affected by instrument strength, instrument contamination, and sample size.
    Crown WH; Henk HJ; Vanness DJ
    Value Health; 2011 Dec; 14(8):1078-84. PubMed ID: 22152177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogeneity bias in the absence of unobserved heterogeneity.
    Berg GD; Mansley EC
    Ann Epidemiol; 2004 Sep; 14(8):561-5. PubMed ID: 15350955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of instrumental variable methods in cohort and nested case-control studies: a simulation study.
    Uddin MJ; Groenwold RH; de Boer A; Belitser SV; Roes KC; Hoes AW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):165-77. PubMed ID: 24306965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Logistic or linear? Estimating causal effects of experimental treatments on binary outcomes using regression analysis.
    Gomila R
    J Exp Psychol Gen; 2021 Apr; 150(4):700-709. PubMed ID: 32969684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Omitting Non-confounding Predictors From General Relative-Risk Models for Binary Outcomes.
    Cologne J; Furukawa K; Grant EJ; Abbott RD
    J Epidemiol; 2019 Mar; 29(3):116-122. PubMed ID: 30101814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instrumental variables technique: cigarette price provided better estimate of effects of smoking on SF-12.
    Leigh JP; Schembri M
    J Clin Epidemiol; 2004 Mar; 57(3):284-93. PubMed ID: 15066689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papers from the 1st European Workshop on Econometrics and Health Economics. York, July 1992.
    Health Econ; 1993 Jul; 2(2):85-198. PubMed ID: 7903181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.